Lv41
410 积分 2023-08-03 加入
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
5小时前
已完结
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
1个月前
已完结
PIK3CA mutations in breast cancer are associated with poor outcome
3个月前
已完结
乳腺癌患者癌组织中KRAS、PIK3CA基因突变与临床病理特征及预后的关系
3个月前
已完结
UK recommendations for HER2 assessment in breast cancer: an update
4个月前
已完结
Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France2021 update of the GEFPICS’ recommendations for HER2 status assessment in invasive breast cancer in France
4个月前
已完结
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis
4个月前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
4个月前
已完结
PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation
4个月前
已关闭
Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
4个月前
已完结
皖公网安备34019202002308
